Nancy Flournoy
About
In The Last Decade
Nancy Flournoy
111 papers receiving 9.5k citations
Hit Papers
Peers
Comparison fields: 5 of 167
- Hematology 5.3k
- Epidemiology 2.7k
- Immunology 2.5k
- Oncology 2.2k
- Public Health, Environmental and Occupational Health 1.2k
Countries citing papers authored by Nancy Flournoy
This map shows the geographic impact of Nancy Flournoy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy Flournoy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy Flournoy more than expected).
Fields of papers citing papers by Nancy Flournoy
This network shows the impact of papers produced by Nancy Flournoy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy Flournoy. The network helps show where Nancy Flournoy may publish in the future.
Co-authorship network of co-authors of Nancy Flournoy
This figure shows the co-authorship network connecting the top 25 collaborators of Nancy Flournoy. A scholar is included among the top collaborators of Nancy Flournoy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy Flournoy. Nancy Flournoy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 5 | |
| 4 | 5 | |
| 5 | Advances in the Mathematical Sciences : Research from the 2015 Association for Women in Mathematics Symposium | 1 |
| 6 | A graphical comparison of response-adaptive randomization procedures | 0 |
| 7 | 6 | |
| 8 | 54 | |
| 9 | 21 | |
| 10 | 74 | |
| 11 | 1 | |
| 12 | 184 | |
| 13 | New developments and applications in experimental design : selected proceedings of a 1997 Joint AMS-IMS-SIAM summer conference | 3 |
| 14 | Adaptive designs : selected proceedings of a 1992 joint AMS-IMS-SIAM summer conference | 2 |
| 15 | 11 | |
| 16 | 18 | |
| 17 | 341 | |
| 18 | 76 | |
| 19 | Aggressive doxorubicin-containing regimen (prednisone, methotrexate, 5-FU, doxorubicin, and cyclophosphamide; PM-FAC) in disseminated estrogen receptor-negative breast cancer. | 2 |
| 20 | Effects of database management on the organization and administration of clinical trials | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.